Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
September 11, 2025 09:00 ET | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows…
Everspin Reports Unaudited Second Quarter 2025 Financial Results
CHANDLER, Ariz.--(BUSINESS WIRE)--Everspin Technologies, Inc. (NASDAQ: MRAM), the world’s leading developer and…
LFG!!! Launches AI Alpha Pilot for Meme-Coin Hunters
Institutional‑grade insights, 10–100× leverage, and a $1 million welcome campaign—live today on iOS…
BrowserStack Becomes the First Platform to Enable Playwright Testing on Real iOS Devices with Safari
DUBLIN, June 12, 2025 /PRNewswire/ -- BrowserStack, the world's leading software testing platform,…
Persistent Achieves Top Rankings for the Second Year in a Row in Extel’s Asia Executive Team Survey
Recognized under multiple categories, including Best CEO, Company Board of Directors, Overall…